Novavax takes the RNA sequence that codes ... vaccine that covers the needs of the space as it is now. The vaccine is approved in over 40 countries and recommended by the WHO.

Life science companies developing bird flu vaccines are gaining attention as the avian influenza subtype H5N1 becomes an ...

These awards were approved by the Compensation C Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that it will ...

Novavax has said it intends to file for ... The UK government has ordered 60 million doses of the protein subunit vaccine, and if approved by the Medicines and Healthcare products Regulatory ...

Researchers at the Icahn School of Medicine at Mount Sinai, led by Nina Bhardwaj, MD, Ph.D., Ward-Coleman Chair in Cancer ...

Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B ...

Novavax , Inc. (NASDAQ:NVAX), a biotechnology company specializing in the development of vaccines with a market capitalization of $1.32 billion, has had a key contract with the Canadian government ...

Novavax (NVAX) announced that James Young, PhD, is retiring as Chair of the Board and Margaret McGlynn, RPh, has been appointed as his ...

(RTTNews) - Novavax, Inc. (NVAX) announced Tuesday that James Young is retiring as Chair of the Board and Margaret McGlynn has been appointed as his successor. The Company also appointed John ...

The COVID-19 vaccine maker reported an earning loss of 51 cents per share, down from $1.44 a year ago, in line with the Wall Street Estimate. Also Read: Wegovy Maker Novo Nordisk To Buy Novavax ...

Pandemic influenza remains a significant global health threat, as signalled by the circulation and cross-species transmission of avian influenza A(H5N1) viruses from the clade 2.3.4.4b, including ...